We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
2701
Voyager Therapeutics
VYGR
$197M
$59.8K ﹤0.01%
15,208
-11,545
-43% -$51.1K
GLOB icon
2702
Globant
GLOB
$1.67B
$59.4K ﹤0.01%
908
-10
-1% -$629
PAYS icon
2703
Paysign
PAYS
$723M
$58.9K ﹤0.01%
11,444
-8,332
-42% -$44.9K
QUAD icon
2704
Quad
QUAD
$507M
$58.9K ﹤0.01%
9,399
-7,097
-43% -$41.7K
NNOX icon
2705
Nano X Imaging
NNOX
$71M
$58.8K ﹤0.01%
21,017
-17,020
-45% -$61.2K
GFS icon
2706
GlobalFoundries
GFS
$29.2B
$58.7K ﹤0.01%
1,681
-32
-2% -$1.14K
MASS icon
2707
908 Devices
MASS
$414M
$57.5K ﹤0.01%
10,948
+582
+6% +$4.07K
ARCT icon
2708
Arcturus Therapeutics
ARCT
$216M
$57.4K ﹤0.01%
9,357
-6,938
-43% -$74.9K
AGL icon
2709
Agilon Health
AGL
$1.45B
$57K ﹤0.01%
3,312
-2,946
-47% -$57.1K
TRAK icon
2710
ReposiTrak
TRAK
$152M
$55.4K ﹤0.01%
4,482
-2,058
-31% -$29.2K
VUZI icon
2711
Vuzix
VUZI
$218M
$54.3K ﹤0.01%
14,368
-11,287
-44% -$35.5K
ZG icon
2712
Zillow
ZG
$7.53B
$53.8K ﹤0.01%
788
-44
-5% -$3.1K
LRMR icon
2713
Larimar Therapeutics
LRMR
$454M
$51.8K ﹤0.01%
13,597
-12,110
-47% -$47.1K
FHB icon
2714
First Hawaiian
FHB
$3.36B
$51K ﹤0.01%
2,017
-71
-3% -$1.76K
WEN icon
2715
Wendy's
WEN
$1.65B
$49.9K ﹤0.01%
5,985
+11
+0.2% +$95
KLC
2716
KinderCare Learning Companies
KLC
$550M
$49.8K ﹤0.01%
11,518
-5,406
-32% -$27.2K
WW
2717
WW International
WW
$144M
$49.3K ﹤0.01%
1,688
-35,163
-95% -$983K
WU icon
2718
Western Union
WU
$2.23B
$48.4K ﹤0.01%
5,196
-160,796
-97% -$1.42M
RGP icon
2719
Resources Connection
RGP
$144M
$47.9K ﹤0.01%
9,500
-8,759
-48% -$41.8K
ALLO icon
2720
Allogene Therapeutics
ALLO
$714M
$47.7K ﹤0.01%
34,823
-22,434
-39% -$29.6K
KLTR icon
2721
Kaltura
KLTR
$241M
$47.4K ﹤0.01%
28,909
-8,747
-23% -$13.8K
CATX icon
2722
Perspective Therapeutics
CATX
$372M
$46K ﹤0.01%
16,717
-12,842
-43% -$36.6K
HCAT icon
2723
Health Catalyst
HCAT
$135M
$45.4K ﹤0.01%
18,979
-19,053
-50% -$52.1K
CWEN icon
2724
Clearway Energy Class C
CWEN
$7.06B
$44.9K ﹤0.01%
1,349
-7
-0.5% -$233
CAI
2725
Caris Life Sciences
CAI
$6.29B
$44.6K ﹤0.01%
1,654
+755
+84% +$21.3K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.